India has been grappling with tuberculosis (TB) for decades, and recent statistics reveal a complex picture. In 2023, the country recorded over 2.5 million new cases, the highest number of notified TB cases to date. However, this increase comes amid encouraging signs of progress in treatment coverage and reduction in mortality rates.
Rising Cases, Falling Rates
The Union Minister of State for Health and Family Welfare, Anupriya Patel, announced that while the number of TB cases has seen a significant rise — from 2.55 million cases in 2023 to 2.607 million in 2024 — the incidence rate has notably decreased by 17.7% since 2015. This decline indicates that while more cases are being reported, the overall prevalence of TB is falling.
Additionally, TB-related deaths have decreased by 21.4% in the same timeframe, highlighting improved healthcare access and treatment efficacy.
Advancements in Treatment
India’s response to tuberculosis has evolved with the introduction of several innovative treatments:
1. Improved Drug-Resistant TB Treatment: The adoption of a shorter, safer oral drug regimen with Bedaquiline has successfully raised treatment success rates from 68% in 2020 to 75% in 2022.
2. mBPaL Regimen for Drug-Resistant TB: This new therapy offers 80% effectiveness and shortens treatment duration to just six months.
3. Nutritional Support: Under the Ni-kshay Poshan Yojana, financial assistance for TB patients increased from ₹500 to ₹1,000 per month starting November 2024, providing critical support for recovery.
4. Community Initiatives: Programs like the Ni-kshay Mitra Initiative aim to bolster community support for TB patients and their families by providing food baskets and additional resources.
5. TB Mukt Bharat Campaign: Launched in December 2024, this intensified campaign spans 455 districts and emphasizes early diagnosis, active case finding, and nutritional support for TB patients.
Innovations in Diagnosis
To combat the challenge of TB detection, India’s medical research institutions have introduced several technological advancements:
– Handheld X-ray Devices: These portable machines facilitate TB screening in hard-to-reach areas while minimizing radiation exposure.
– AI-Powered Analysis: The DeepCXR tool employs artificial intelligence to speed up TB detection from chest X-rays, increasing diagnostic efficiency.
– New Testing Protocols: Innovations like the CyTb skin test for latent TB and the PathoDetect™ NAAT test for simultaneous TB and drug resistance detection represent significant breakthroughs in diagnostics.
The Road Ahead
Despite these advancements, challenges remain. The increase in TB cases signals areas for improvement in public health strategies and outreach. The government’s commitment to eliminate other diseases, including leprosy and malaria, in the coming years further underscores the need for an integrated approach to TB control.
India is poised to release its progress report on the TB Mukt Bharat campaign on World TB Day, March 24, 2025. This report will highlight ongoing efforts and chart a path forward in the battle against tuberculosis.
-Raja Aditya
